Jane Street’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,918,127
| Closed | -$1.16M | – | 12846 |
|
|
2025
Q4 | $1.23M | Buy |
2,918,127
+717,442
| +33% | +$380K | ﹤0.01% | 5736 |
|
|
2025
Q3 | $1.48M | Buy |
+2,200,685
| New | +$1.19M | ﹤0.01% | 5492 |
|
|
2025
Q1 | – | Sell |
-152,933
| Closed | -$162K | – | 10492 |
|
|
2024
Q4 | $156K | Sell |
152,933
-170,927
| -53% | -$312K | ﹤0.01% | 8560 |
|
|
2024
Q3 | $280K | Sell |
323,860
-276,777
| -46% | -$203K | ﹤0.01% | 8139 |
|
|
2024
Q2 | $215K | Buy |
600,637
+566,101
| +1,639% | +$306K | ﹤0.01% | 8280 |
|
|
2024
Q1 | $23.1K | Sell |
34,536
-103,502
| -75% | -$75.1K | ﹤0.01% | 8880 |
|
|
2023
Q4 | $75K | Buy |
+138,038
| New | +$63.6K | ﹤0.01% | 8678 |
|
|
2023
Q3 | – | Sell |
-664,704
| Closed | -$864K | – | 9304 |
|
|
2023
Q2 | $864K | Buy |
+664,704
| New | +$908K | ﹤0.01% | 5456 |
|
|
2022
Q4 | – | Sell |
-109,356
| Closed | -$424K | – | 10053 |
|
|
2022
Q3 | $536K | Buy |
109,356
+21,115
| +24% | +$108K | ﹤0.01% | 6570 |
|
|
2022
Q2 | $366K | Buy |
88,241
+1,268
| +1% | +$5.48K | ﹤0.01% | 7274 |
|
|
2022
Q1 | $505K | Buy |
86,973
+23,140
| +36% | +$138K | ﹤0.01% | 7460 |
|
|
2021
Q4 | $479K | Buy |
63,833
+30,337
| +91% | +$264K | ﹤0.01% | 7347 |
|
|
2021
Q3 | $302K | Buy |
33,496
+21,875
| +188% | +$216K | ﹤0.01% | 8163 |
|
|
2021
Q2 | $139K | Sell |
11,621
-32,017
| -73% | -$363K | ﹤0.01% | 9093 |
|
|
2021
Q1 | $547K | Sell |
43,638
-141,696
| -76% | -$1.91M | ﹤0.01% | 6637 |
|
|
2020
Q4 | $2.89M | Sell |
185,334
-14,426
| -7% | -$169K | ﹤0.01% | 2871 |
|
|
2020
Q3 | $1.89M | Buy |
199,760
+80,374
| +67% | +$869K | ﹤0.01% | 3133 |
|
|
2020
Q2 | $1.07M | Buy |
119,386
+91,640
| +330% | +$850K | ﹤0.01% | 3965 |
|
|
2020
Q1 | $177K | Buy |
27,746
+15,725
| +131% | +$117K | ﹤0.01% | 4704 |
|
|
2019
Q4 | $101K | Sell |
12,021
-24,420
| -67% | -$225K | ﹤0.01% | 4853 |
|
|
2019
Q3 | $330K | Buy |
+36,441
| New | +$409K | ﹤0.01% | 4060 |
|
|
2019
Q2 | – | Sell |
-45,450
| Closed | -$433K | – | 5661 |
|
|
2019
Q1 | $433K | Buy |
45,450
+21,723
| +92% | +$222K | ﹤0.01% | 3838 |
|
|
2018
Q4 | $272K | Sell |
23,727
-15,064
| -39% | -$187K | ﹤0.01% | 4180 |
|
|
2018
Q3 | $658K | Buy |
+38,791
| New | +$590K | ﹤0.01% | 3293 |
|
|
2018
Q2 | – | Sell |
-56,222
| Closed | -$934K | – | 5547 |
|
|
2018
Q1 | $1.07M | Buy |
56,222
+36,667
| +188% | +$784K | ﹤0.01% | 2579 |
|
|
2017
Q4 | $321K | Sell |
19,555
-22,036
| -53% | -$328K | ﹤0.01% | 3687 |
|
|
2017
Q3 | $624K | Buy |
+41,591
| New | +$460K | ﹤0.01% | 2825 |
|
|
2016
Q2 | – | Sell |
-27,160
| Closed | -$164K | – | 4533 |
|
|
2016
Q1 | $164K | Buy |
+27,160
| New | +$163K | ﹤0.01% | 3769 |
|
|
2015
Q3 | – | Sell |
-35,393
| Closed | -$393K | – | 4085 |
|
|
2015
Q2 | $393K | Buy |
+35,393
| New | +$456K | ﹤0.01% | 2527 |
|
|
2015
Q1 | – | Sell |
-43,107
| Closed | -$656K | – | 3439 |
|
|
2014
Q4 | $656K | Buy |
43,107
+33,107
| +331% | +$402K | ﹤0.01% | 1320 |
|
|
2014
Q3 | $108K | Sell |
10,000
-3,443
| -26% | -$45K | ﹤0.01% | 2350 |
|
|
2014
Q2 | $205K | Buy |
+13,443
| New | +$193K | ﹤0.01% | 2184 |
|
|
2013
Q4 | – | Sell |
-39,124
| Closed | -$410K | – | 2824 |
|
|
2013
Q3 | $410K | Sell |
39,124
-84,559
| -68% | -$840K | ﹤0.01% | 1859 |
|
|
2013
Q2 | $966K | Buy |
+123,683
| New | +$1.08M | 0.02% | 947 |
|
Other funds holding SGMO
AC
VCM
VFT
Jane Street's SGMO Position: Q1 2026 in Review
Jane Street sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 2,918,127 shares — an estimated $1.16M sold.
Jane Street first reported a position in SGMO in Q2 2013 and held it in 34 quarters. The position peaked at $2.89M in Q4 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.
- Jane Street reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
- Jane Street sold 2,918,127 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $1.16M.
- Jane Street first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 34 quarters.
- Jane Street's SANGAMO THERAPEUTICS INC position peaked at $2.89M in Q4 2020.
- 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.